Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives.
When certain drugs are taken concomitantly with an oral contraceptive, the efficacy of the contraceptive may be obtunded, and pregnancy may ensue. Since the function of oral contraceptives is to suppress ovulation, the risk of ovulation is an important parameter in clinical studies investigating interactions between drugs and oral contraceptives. The purpose of this paper is to compare a crossover design, and a new study design used for assessing a possible interaction between a drug and an oral contraceptive, and to discuss the statistical issues involved in the planning and evaluation of the results of such studies.
de la Rey
N
N
FARMOVS Institute for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, Republic of South Africa.
Schall
R
R
Luus
H G
HG
Meyer
B H
BH
Müller
F O
FO
D016001:Confidence Intervals; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012107:Research Design; D012307:Risk Factors; D015575:Roxithromycin / Q000008:administration & dosage
D003276:Contraceptives, Oral; D015575:Roxithromycin